1 Market Overview

1.1 Product Overview and Scope of Endothelin Antagonist Therapy

1.2 Global Endothelin Antagonist Therapy Market Size and Forecast

1.3 China Endothelin Antagonist Therapy Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Endothelin Antagonist Therapy Share in Global Market, 2018-2029

1.4.2 Endothelin Antagonist Therapy Market Size: China VS Global, 2018-2029

1.5 Endothelin Antagonist Therapy Market Dynamics

1.5.1 Endothelin Antagonist Therapy Market Drivers

1.5.2 Endothelin Antagonist Therapy Market Restraints

1.5.3 Endothelin Antagonist Therapy Industry Trends

1.5.4 Endothelin Antagonist Therapy Industry Policy

2 Global Competitive Situation by Company

2.1 Global Endothelin Antagonist Therapy Revenue by Company (2018-2023)

2.2 Global Endothelin Antagonist Therapy Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Endothelin Antagonist Therapy Concentration Ratio

2.4 Global Endothelin Antagonist Therapy Mergers & Acquisitions, Expansion Plans

2.5 Global Endothelin Antagonist Therapy Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Endothelin Antagonist Therapy Revenue by Company (2018-2023)

3.2 China Endothelin Antagonist Therapy Endothelin Antagonist Therapy Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Endothelin Antagonist Therapy, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)

4 Industry Chain Analysis

4.1 Endothelin Antagonist Therapy Industry Chain

4.2 Endothelin Antagonist Therapy Upstream Analysis

4.3 Endothelin Antagonist Therapy Midstream Analysis

4.4 Endothelin Antagonist Therapy Downstream Analysis

5 Sights by Type

5.1 Endothelin Antagonist Therapy Classification

5.1.1 Oral

5.1.2 Parenteral

5.2 By Type, Global Endothelin Antagonist Therapy Market Size & CAGR, 2018 VS 2022 VS 2029

5.3 By Type, Global Endothelin Antagonist Therapy Revenue, 2018-2029

6 Sights by Application

6.1 Endothelin Antagonist Therapy Segment by Application

6.1.1 Hospitals

6.1.2 Specialty Clinics

6.1.3 Diagnostic Centers

6.1.4 Others

6.2 By Application, Global Endothelin Antagonist Therapy Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Application, Global Endothelin Antagonist Therapy Revenue, 2018-2029

7 Sales Sights by Region

7.1 By Region, Global Endothelin Antagonist Therapy Market Size, 2018 VS 2022 VS 2029

7.2 By Region, Global Endothelin Antagonist Therapy Market Size, 2018-2029

7.3 North America

7.3.1 North America Endothelin Antagonist Therapy Market Size & Forecasts, 2018-2029

7.3.2 By Country, North America Endothelin Antagonist Therapy Market Size Market Share

7.4 Europe

7.4.1 Europe Endothelin Antagonist Therapy Market Size & Forecasts, 2018-2029

7.4.2 By Country, Europe Endothelin Antagonist Therapy Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Endothelin Antagonist Therapy Market Size & Forecasts, 2018-2029

7.5.2 By Country/Region, Asia Pacific Endothelin Antagonist Therapy Market Size Market Share

7.6 South America

7.6.1 South America Endothelin Antagonist Therapy Market Size & Forecasts, 2018-2029

7.6.2 By Country, South America Endothelin Antagonist Therapy Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Endothelin Antagonist Therapy Market Size & CAGR，2018 VS 2022 VS 2029

8.2 By Country, Global Endothelin Antagonist Therapy Market Size, 2018-2029

8.3 U.S.

8.3.1 U.S. Endothelin Antagonist Therapy Market Size, 2018-2029

8.3.2 By Company, U.S. Endothelin Antagonist Therapy Revenue Market Share, 2018-2023

8.3.3 By Type, U.S. Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

8.3.4 By Application, U.S. Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

8.4 Europe

8.4.1 Europe Endothelin Antagonist Therapy Market Size, 2018-2029

8.4.2 By Company, Europe Endothelin Antagonist Therapy Revenue Market Share, 2018-2023

8.4.3 By Type, Europe Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

8.4.4 By Application, Europe Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

8.5 China

8.5.1 China Endothelin Antagonist Therapy Market Size, 2018-2029

8.5.2 By Company, China Endothelin Antagonist Therapy Revenue Market Share, 2018-2023

8.5.3 By Type, China Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

8.5.4 By Application, China Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

8.6 Japan

8.6.1 Japan Endothelin Antagonist Therapy Market Size, 2018-2029

8.6.2 By Company, Japan Endothelin Antagonist Therapy Revenue Market Share, 2018-2023

8.6.3 By Type, Japan Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

8.6.4 By Application, Japan Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

8.7 South Korea

8.7.1 South Korea Endothelin Antagonist Therapy Market Size, 2018-2029

8.7.2 By Company, South Korea Endothelin Antagonist Therapy Revenue Market Share, 2018-2023

8.7.3 By Type, South Korea Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

8.7.4 By Application, South Korea Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

8.8 Southeast Asia

8.8.1 Southeast Asia Endothelin Antagonist Therapy Market Size, 2018-2029

8.8.2 By Company, Southeast Asia Endothelin Antagonist Therapy Revenue Market Share, 2018-2023

8.8.3 By Type, Southeast Asia Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

8.8.4 By Application, Southeast Asia Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

8.9 India

8.9.1 India Endothelin Antagonist Therapy Market Size, 2018-2029

8.9.2 By Company, India Endothelin Antagonist Therapy Revenue Market Share, 2018-2023

8.9.3 By Type, India Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

8.9.4 By Application, India Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

8.10 Middle East & Asia

8.10.1 Middle East & Asia Endothelin Antagonist Therapy Market Size, 2018-2029

8.10.2 By Company, Middle East & Asia Endothelin Antagonist Therapy Revenue Market Share, 2018-2023

8.10.3 By Type, Middle East & Asia Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

8.10.4 By Application, Middle East & Asia Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

9 Global Manufacturers Profile

9.1 Gilead Sciences

9.1.1 Gilead Sciences Company Information, Head Office, Market Area and Industry Position

9.1.2 Gilead Sciences Company Profile and Main Business

9.1.3 Gilead Sciences Endothelin Antagonist Therapy Models, Specifications and Application

9.1.4 Gilead Sciences Endothelin Antagonist Therapy Revenue and Gross Margin, 2018-2023

9.1.5 Gilead Sciences Recent Developments

9.2 Sun Pharmaceutical Industries

9.2.1 Sun Pharmaceutical Industries Company Information, Head Office, Market Area and Industry Position

9.2.2 Sun Pharmaceutical Industries Company Profile and Main Business

9.2.3 Sun Pharmaceutical Industries Endothelin Antagonist Therapy Models, Specifications and Application

9.2.4 Sun Pharmaceutical Industries Endothelin Antagonist Therapy Revenue and Gross Margin, 2018-2023

9.2.5 Sun Pharmaceutical Industries Recent Developments

9.3 Lupin

9.3.1 Lupin Company Information, Head Office, Market Area and Industry Position

9.3.2 Lupin Company Profile and Main Business

9.3.3 Lupin Endothelin Antagonist Therapy Models, Specifications and Application

9.3.4 Lupin Endothelin Antagonist Therapy Revenue and Gross Margin, 2018-2023

9.3.5 Lupin Recent Developments

9.4 Zydus Group

9.4.1 Zydus Group Company Information, Head Office, Market Area and Industry Position

9.4.2 Zydus Group Company Profile and Main Business

9.4.3 Zydus Group Endothelin Antagonist Therapy Models, Specifications and Application

9.4.4 Zydus Group Endothelin Antagonist Therapy Revenue and Gross Margin, 2018-2023

9.4.5 Zydus Group Recent Developments

9.5 Endo International

9.5.1 Endo International Company Information, Head Office, Market Area and Industry Position

9.5.2 Endo International Company Profile and Main Business

9.5.3 Endo International Endothelin Antagonist Therapy Models, Specifications and Application

9.5.4 Endo International Endothelin Antagonist Therapy Revenue and Gross Margin, 2018-2023

9.5.5 Endo International Recent Developments

9.6 Mylan N.V

9.6.1 Mylan N.V Company Information, Head Office, Market Area and Industry Position

9.6.2 Mylan N.V Company Profile and Main Business

9.6.3 Mylan N.V Endothelin Antagonist Therapy Models, Specifications and Application

9.6.4 Mylan N.V Endothelin Antagonist Therapy Revenue and Gross Margin, 2018-2023

9.6.5 Mylan N.V Recent Developments

9.7 Teva Pharmaceutical Industries

9.7.1 Teva Pharmaceutical Industries Company Information, Head Office, Market Area and Industry Position

9.7.2 Teva Pharmaceutical Industries Company Profile and Main Business

9.7.3 Teva Pharmaceutical Industries Endothelin Antagonist Therapy Models, Specifications and Application

9.7.4 Teva Pharmaceutical Industries Endothelin Antagonist Therapy Revenue and Gross Margin, 2018-2023

9.7.5 Teva Pharmaceutical Industries Recent Developments

9.8 Sigmapharm Laboratories

9.8.1 Sigmapharm Laboratories Company Information, Head Office, Market Area and Industry Position

9.8.2 Sigmapharm Laboratories Company Profile and Main Business

9.8.3 Sigmapharm Laboratories Endothelin Antagonist Therapy Models, Specifications and Application

9.8.4 Sigmapharm Laboratories Endothelin Antagonist Therapy Revenue and Gross Margin, 2018-2023

9.8.5 Sigmapharm Laboratories Recent Developments

9.9 Alembic Pharmaceuticals

9.9.1 Alembic Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

9.9.2 Alembic Pharmaceuticals Company Profile and Main Business

9.9.3 Alembic Pharmaceuticals Endothelin Antagonist Therapy Models, Specifications and Application

9.9.4 Alembic Pharmaceuticals Endothelin Antagonist Therapy Revenue and Gross Margin, 2018-2023

9.9.5 Alembic Pharmaceuticals Recent Developments

9.10 Hikma Pharmaceuticals

9.10.1 Hikma Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

9.10.2 Hikma Pharmaceuticals Company Profile and Main Business

9.10.3 Hikma Pharmaceuticals Endothelin Antagonist Therapy Models, Specifications and Application

9.10.4 Hikma Pharmaceuticals Endothelin Antagonist Therapy Revenue and Gross Margin, 2018-2023

9.10.5 Hikma Pharmaceuticals Recent Developments

9.11 Amneal Pharmaceuticals

9.11.1 Amneal Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

9.11.2 Amneal Pharmaceuticals Company Profile and Main Business

9.11.3 Amneal Pharmaceuticals Endothelin Antagonist Therapy Models, Specifications and Application

9.11.4 Amneal Pharmaceuticals Endothelin Antagonist Therapy Revenue and Gross Margin, 2018-2023

9.11.5 Amneal Pharmaceuticals Recent Developments

9.12 AstraZeneca

9.12.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position

9.12.2 AstraZeneca Company Profile and Main Business

9.12.3 AstraZeneca Endothelin Antagonist Therapy Models, Specifications and Application

9.12.4 AstraZeneca Endothelin Antagonist Therapy Revenue and Gross Margin, 2018-2023

9.12.5 AstraZeneca Recent Developments

9.13 Johnsons & Johnsons Private limited

9.13.1 Johnsons & Johnsons Private limited Company Information, Head Office, Market Area and Industry Position

9.13.2 Johnsons & Johnsons Private limited Company Profile and Main Business

9.13.3 Johnsons & Johnsons Private limited Endothelin Antagonist Therapy Models, Specifications and Application

9.13.4 Johnsons & Johnsons Private limited Endothelin Antagonist Therapy Revenue and Gross Margin, 2018-2023

9.13.5 Johnsons & Johnsons Private limited Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Table 1. Endothelin Antagonist Therapy Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. Endothelin Antagonist Therapy Market Restraints

Table 3. Endothelin Antagonist Therapy Market Trends

Table 4. Endothelin Antagonist Therapy Industry Policy

Table 5. Global Endothelin Antagonist Therapy Revenue by Company (2018-2023) & (US$ million)

Table 6. Global Endothelin Antagonist Therapy Revenue Market Share by Company (2018-2023)

Table 7. Global Endothelin Antagonist Therapy Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Endothelin Antagonist Therapy Mergers & Acquisitions, Expansion Plans

Table 9. Global Endothelin Antagonist Therapy Manufacturers Product Type

Table 10. China Endothelin Antagonist Therapy Revenue by Company (2018-2023) & (US$ million)

Table 11. China Endothelin Antagonist Therapy Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of Endothelin Antagonist Therapy Upstream (Raw Materials)

Table 13. Global Endothelin Antagonist Therapy Typical Customers

Table 14. Endothelin Antagonist Therapy Typical Distributors

Table 15. By Type, Global Endothelin Antagonist Therapy Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Application, Global Endothelin Antagonist Therapy Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global Endothelin Antagonist Therapy Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Endothelin Antagonist Therapy Revenue, 2018-2029, US$ Million

Table 19. By Country, Global Endothelin Antagonist Therapy Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global Endothelin Antagonist Therapy Revenue, 2018-2029, US$ Million

Table 21. By Country, Global Endothelin Antagonist Therapy Revenue Market Share, 2018-2029

Table 22. Gilead Sciences Company Information, Head Office, Market Area and Industry Position

Table 23. Gilead Sciences Company Profile and Main Business

Table 24. Gilead Sciences Endothelin Antagonist Therapy Models, Specifications and Application

Table 25. Gilead Sciences Endothelin Antagonist Therapy Revenue and Gross Margin, 2018-2023

Table 26. Gilead Sciences Recent Developments

Table 27. Sun Pharmaceutical Industries Company Information, Head Office, Market Area and Industry Position

Table 28. Sun Pharmaceutical Industries Company Profile and Main Business

Table 29. Sun Pharmaceutical Industries Endothelin Antagonist Therapy Models, Specifications and Application

Table 30. Sun Pharmaceutical Industries Endothelin Antagonist Therapy Revenue and Gross Margin, 2018-2023

Table 31. Sun Pharmaceutical Industries Recent Developments

Table 32. Lupin Company Information, Head Office, Market Area and Industry Position

Table 33. Lupin Company Profile and Main Business

Table 34. Lupin Endothelin Antagonist Therapy Models, Specifications and Application

Table 35. Lupin Endothelin Antagonist Therapy Revenue and Gross Margin, 2018-2023

Table 36. Lupin Recent Developments

Table 37. Zydus Group Company Information, Head Office, Market Area and Industry Position

Table 38. Zydus Group Company Profile and Main Business

Table 39. Zydus Group Endothelin Antagonist Therapy Models, Specifications and Application

Table 40. Zydus Group Endothelin Antagonist Therapy Revenue and Gross Margin, 2018-2023

Table 41. Zydus Group Recent Developments

Table 42. Endo International Company Information, Head Office, Market Area and Industry Position

Table 43. Endo International Company Profile and Main Business

Table 44. Endo International Endothelin Antagonist Therapy Models, Specifications and Application

Table 45. Endo International Endothelin Antagonist Therapy Revenue and Gross Margin, 2018-2023

Table 46. Endo International Recent Developments

Table 47. Mylan N.V Company Information, Head Office, Market Area and Industry Position

Table 48. Mylan N.V Company Profile and Main Business

Table 49. Mylan N.V Endothelin Antagonist Therapy Models, Specifications and Application

Table 50. Mylan N.V Endothelin Antagonist Therapy Revenue and Gross Margin, 2018-2023

Table 51. Mylan N.V Recent Developments

Table 52. Teva Pharmaceutical Industries Company Information, Head Office, Market Area and Industry Position

Table 53. Teva Pharmaceutical Industries Company Profile and Main Business

Table 54. Teva Pharmaceutical Industries Endothelin Antagonist Therapy Models, Specifications and Application

Table 55. Teva Pharmaceutical Industries Endothelin Antagonist Therapy Revenue and Gross Margin, 2018-2023

Table 56. Teva Pharmaceutical Industries Recent Developments

Table 57. Sigmapharm Laboratories Company Information, Head Office, Market Area and Industry Position

Table 58. Sigmapharm Laboratories Company Profile and Main Business

Table 59. Sigmapharm Laboratories Endothelin Antagonist Therapy Models, Specifications and Application

Table 60. Sigmapharm Laboratories Endothelin Antagonist Therapy Revenue and Gross Margin, 2018-2023

Table 61. Sigmapharm Laboratories Recent Developments

Table 62. Alembic Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 63. Alembic Pharmaceuticals Company Profile and Main Business

Table 64. Alembic Pharmaceuticals Endothelin Antagonist Therapy Models, Specifications and Application

Table 65. Alembic Pharmaceuticals Endothelin Antagonist Therapy Revenue and Gross Margin, 2018-2023

Table 66. Alembic Pharmaceuticals Recent Developments

Table 67. Hikma Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 68. Hikma Pharmaceuticals Company Profile and Main Business

Table 69. Hikma Pharmaceuticals Endothelin Antagonist Therapy Models, Specifications and Application

Table 70. Hikma Pharmaceuticals Endothelin Antagonist Therapy Revenue and Gross Margin, 2018-2023

Table 71. Hikma Pharmaceuticals Recent Developments

Table 72. Amneal Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 73. Amneal Pharmaceuticals Company Profile and Main Business

Table 74. Amneal Pharmaceuticals Endothelin Antagonist Therapy Models, Specifications and Application

Table 75. Amneal Pharmaceuticals Endothelin Antagonist Therapy Revenue and Gross Margin, 2018-2023

Table 76. Amneal Pharmaceuticals Recent Developments

Table 77. AstraZeneca Company Information, Head Office, Market Area and Industry Position

Table 78. AstraZeneca Company Profile and Main Business

Table 79. AstraZeneca Endothelin Antagonist Therapy Models, Specifications and Application

Table 80. AstraZeneca Endothelin Antagonist Therapy Revenue and Gross Margin, 2018-2023

Table 81. AstraZeneca Recent Developments

Table 82. Johnsons & Johnsons Private limited Company Information, Head Office, Market Area and Industry Position

Table 83. Johnsons & Johnsons Private limited Company Profile and Main Business

Table 84. Johnsons & Johnsons Private limited Endothelin Antagonist Therapy Models, Specifications and Application

Table 85. Johnsons & Johnsons Private limited Endothelin Antagonist Therapy Revenue and Gross Margin, 2018-2023

Table 86. Johnsons & Johnsons Private limited Recent Developments

List of Figure

Figure 1. Endothelin Antagonist Therapy Picture

Figure 2. Global Endothelin Antagonist Therapy Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China Endothelin Antagonist Therapy Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China Endothelin Antagonist Therapy Market Share of Global

Figure 5. Global Endothelin Antagonist Therapy Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Endothelin Antagonist Therapy Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China Endothelin Antagonist Therapy Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Endothelin Antagonist Therapy Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. Endothelin Antagonist Therapy Industry Chain

Figure 10. Oral

Figure 11. Parenteral

Figure 12. By Type, Global Endothelin Antagonist Therapy Revenue, 2018-2029, US$ Million

Figure 13. By Type, Global Endothelin Antagonist Therapy Revenue Market Share, 2018-2029

Figure 14. Hospitals

Figure 15. Specialty Clinics

Figure 16. Diagnostic Centers

Figure 17. Others

Figure 18. By Application, Global Endothelin Antagonist Therapy Revenue, 2018-2029, US$ Million

Figure 19. By Application, Global Endothelin Antagonist Therapy Revenue Market Share, 2018-2029

Figure 20. By Region, Global Endothelin Antagonist Therapy Revenue Market Share, 2018-2029

Figure 21. North America Endothelin Antagonist Therapy Revenue & Forecasts, 2018-2029, US$ Million

Figure 22. By Country, North America Endothelin Antagonist Therapy Revenue Market Share, 2018-2023

Figure 23. Europe Endothelin Antagonist Therapy Revenue & Forecasts, 2018-2029, US$ Million

Figure 24. By Country, Europe Endothelin Antagonist Therapy Revenue Market Share, 2018-2023

Figure 25. Asia Pacific Endothelin Antagonist Therapy Revenue & Forecasts, 2018-2029, US$ Million

Figure 26. By Country/Region, Asia Pacific Endothelin Antagonist Therapy Revenue Market Share, 2018-2023

Figure 27. South America Endothelin Antagonist Therapy Revenue & Forecasts, 2018-2029, US$ Million

Figure 28. By Country, South America Endothelin Antagonist Therapy Revenue Market Share, 2018-2023

Figure 29. Middle East & Africa Endothelin Antagonist Therapy Revenue & Forecasts, 2018-2029, US$ Million

Figure 30. U.S. Endothelin Antagonist Therapy Revenue, 2018-2029, (US$ Million)

Figure 31. By Company, U.S. Endothelin Antagonist Therapy Market Share, 2018-2023

Figure 32. By Type, U.S. Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

Figure 33. By Application, U.S. Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

Figure 34. Europe Endothelin Antagonist Therapy Revenue, 2018-2029, (US$ Million)

Figure 35. By Company, Europe Endothelin Antagonist Therapy Market Share, 2018-2023

Figure 36. By Type, Europe Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

Figure 37. By Application, Europe Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

Figure 38. China Endothelin Antagonist Therapy Revenue, 2018-2029, (US$ Million)

Figure 39. By Company, China Endothelin Antagonist Therapy Market Share, 2018-2023

Figure 40. By Type, China Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

Figure 41. By Application, China Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

Figure 42. Japan Endothelin Antagonist Therapy Revenue, 2018-2029, (US$ Million)

Figure 43. By Company, Japan Endothelin Antagonist Therapy Market Share, 2018-2023

Figure 44. By Type, Japan Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

Figure 45. By Application, Japan Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

Figure 46. South Korea Endothelin Antagonist Therapy Revenue, 2018-2029, (US$ Million)

Figure 47. By Company, South Korea Endothelin Antagonist Therapy Market Share, 2018-2023

Figure 48. By Type, South Korea Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

Figure 49. By Application, South Korea Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

Figure 50. Southeast Asia Endothelin Antagonist Therapy Revenue, 2018-2029, (US$ Million)

Figure 51. By Company, Southeast Asia Endothelin Antagonist Therapy Market Share, 2018-2023

Figure 52. By Type, Southeast Asia Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

Figure 53. By Application, Southeast Asia Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

Figure 54. India Endothelin Antagonist Therapy Revenue, 2018-2029, (US$ Million)

Figure 55. By Company, India Endothelin Antagonist Therapy Market Share, 2018-2023

Figure 56. By Type, India Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

Figure 57. By Application, India Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

Figure 58. Middle East & Asia Endothelin Antagonist Therapy Revenue, 2018-2029, (US$ Million)

Figure 59. By Company, Middle East & Asia Endothelin Antagonist Therapy Market Share, 2018-2023

Figure 60. By Type, Middle East & Asia Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

Figure 61. By Application, Middle East & Asia Endothelin Antagonist Therapy Revenue Market Share, 2022 VS 2029

Figure 62. Research Methodology

Figure 63. Breakdown of Primary Interviews

Figure 64. Bottom-up Approaches

Figure 65. Top-down Approaches